COMP <GO>
CYPH vs ARCT // ENTERPRISE SCALE & MARKET CAP
Cypherpunk Technologies Inc. (NASDAQ) VS. Arcturus Therapeutics Holdings Inc. (NASDAQ) • 15-METRIC TALLY: CYPH 5
— ARCT 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: CYPH
LAST: $3.31 (+2.16%) • MKT CAP: $356.7M
market-cap
$356.7M
LAST: $12.15 (+0.66%) • MKT CAP: $345.3M
market-cap
$345.3M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CYPH VS. ARCT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CYPH | ARCT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -23.30% | -35.00% | +11.70 | CYPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.31% | -21.57% | +9.26 | CYPH | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -46.10% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 1.25 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | CYPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.0 | 44.5 | +6.42 | CYPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 66.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $356.7M | $345.3M | $11.4M | CYPH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CYPH REV | ARCT REV | CYPH GROSS % | ARCT GROSS % | CYPH FCF | ARCT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $82.0M | — | — | -$43.9M | -$74.5M |
| FY 2024 | $0 | $152.3M | — | — | -$60.3M | -$60.4M |
| FY 2023 | $0 | $166.8M | — | — | -$43.8M | -$18.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CYPH // BETA —
ARCT // BETA —